Skip to main content
TipRanks
Go Ultimate75% OFF

Orthofix Medical (OFIX) Stock Price & Analysis

94 Followers

OFIX Stock Chart & Stats

$7.17$0.23(3.31%)
At close: 4:00 PM EST
$7$8$9$10Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$7.09 - $7.32
52-Week Range
$6.52 - $16.42
Previous Close
$6.94
Volume
N/A
Average Volume (3M)
584.14K
Market Cap
$292.25M
Enterprise Value
$562.65M
Total Cash (Recent Filing)
$86.32M
Total Debt (Recent Filing)
$234.85M
Price to Earnings (P/E)
―
Beta
0.89
Next Earnings
Feb 19, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue And Margin Improvement

Strong revenue growth alongside higher EBITDA margins indicates improving operating leverage and better execution. Although profitability is not complete, the combination of scale and cost discipline can strengthen earnings capacity and provide a more durable foundation for future investment.

Limb Reconstruction Adoption

Growth in Limb Reconstruction is supported by continued adoption of named products and strong international demand, rather than only broad market expansion. This creates a durable growth channel that can diversify Orthofix beyond weaker spinal markets over coming quarters.

Commercial Partner Productivity

Concentrating resources behind stronger distributors and improving asset turns can make the commercial model more productive and focused. Over time, this approach may improve account execution, reduce inefficient relationships, and support better returns from the spinal portfolio.

Bears Say

Persistent Cash Burn

Deeply negative free cash flow means the business is not currently self-funding despite improving revenue and EBITDA. Continued investment or working-capital needs may require external financing or constrain strategic flexibility until cash conversion improves consistently.

Incomplete Profitability And Rising Leverage

Ongoing net losses limit the benefit of gross-margin and EBITDA progress, while higher leverage reduces flexibility relative to prior periods. Together, these factors can constrain investment capacity and leave less room to absorb operating setbacks over the next several quarters.

Spine Execution And MDR Headwinds

Weak U.S. Spine performance and execution constraints threaten an important product area, while MDR requirements create a defined regulatory revenue reduction. The combined pressure may delay portfolio growth and require sustained investment before the business regains momentum.

Orthofix Medical News

OFIX FAQ

What was Orthofix Medical’s price range in the past 12 months?
Orthofix Medical lowest stock price was $6.52 and its highest was $16.42 in the past 12 months.
What is Orthofix Medical’s market cap?
Orthofix Medical’s market cap is $292.25M.
When is Orthofix Medical’s upcoming earnings report date?
Orthofix Medical’s next earnings report is estimated for Feb 19, 2027 (not yet confirmed), which is in 94 days.
How were Orthofix Medical’s earnings last quarter?
Orthofix Medical released its earnings results on Nov 09, 2026. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.265 by $0.115.
Is Orthofix Medical overvalued?
According to Wall Street analysts Orthofix Medical’s price is currently Undervalued.
Does Orthofix Medical pay dividends?
Orthofix Medical does not currently pay dividends.
What is Orthofix Medical’s EPS estimate?
Orthofix Medical’s EPS estimate is -0.07.
How many shares outstanding does Orthofix Medical have?
Orthofix Medical has 40,759,800 shares outstanding.
What happened to Orthofix Medical’s price movement after its last earnings report?
Orthofix Medical reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.265. Following the earnings report the stock price went up 0.381%.
Which hedge fund is a major shareholder of Orthofix Medical?
Hedge funds hold Orthofix Medical shares: the largest hedge-fund position in Orthofix Medical is 72,325,997 shares, and hedge funds increased their holdings by 201.2K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology